-+ 0.00%
-+ 0.00%
-+ 0.00%

Cho-A Pharma at risk of KOSDAQ watchlist as market cap stays below KRW 20 billion threshold

PUBT·10/07/2026 08:01:36
Listen to the news
Cho-A Pharma at risk of KOSDAQ watchlist as market cap stays below KRW 20 billion threshold
  • Cho-A Pharmaceutical faces potential KOSDAQ “management issue” designation if its common-share market cap stays below KRW 20 billion.
  • As of 2026-10-07, the market cap has remained under KRW 20 billion for 25 consecutive trading days.
  • A further five consecutive trading days below the threshold from 2026-10-08 could trigger the designation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cho-A Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007900474), on October 07, 2026, and is solely responsible for the information contained therein.